@FiercePharma: GlaxoSmithKline pledges $7.1B to add Novartis vaccines to its leading lineup. Story | Follow @FiercePharma
@TracyStaton: All of FiercePharma
@EricPFierce: FDA says import alert for saline from Baxter Canada plant tied to an importer trying to ship some to the U.S. Article | Follow @EricPFierce
@CarlyHFierce: So...who inherits Glaxo's cancer vaccine candidate? | Follow @CarlyHFierce
> The FDA has approved Eli Lilly's ($LLY) blockbuster hopeful, cancer med Cyramza. Story
> The Oklahoma Supreme Court has put a hold on the executions of two inmates it says have the right to challenge the secrecy around the drugs the state will use to put them to death. Story
> CEO Joe Jimenez says today's announced restructuring of Novartis' ($NVS) vaccine, animal health and consumer health businesses doesn't mean the Swiss drugmaker won't still be looking for some acquisitions to round out Novartis' three core operations. Story
> Taiho, the Japanese partner of Spanish pharmaceutical company Zeltia, will seek approval in Japan for their cancer drug Yondelis, which is already approved in 75 countries. Story
> China's Shanghai Fosun Pharmaceutical Group and private equity firm TPG Capital have a deal to buy Chinese hospital operator Chindex International for about $461 million. Story
> India's Lupin has named Theresa Stevens, formerly of Astellas and Novartis ($NVS), as chief corporate development officer for its global operations. Release
@FierceMedDev: Ulthera looks to $86M public offering for financial facelift. News | Follow @FierceMedDev
@VarunSaxena2: Updated with statement from Edwards: Federal court postpones Edwards' block of Medtronic's CoreValve. Story | Follow @VarunSaxena2
@EmilyWFierce: Bacterin International reports slight increase in Q1 revenues partly fueled by biologics growth. More | Follow @EmilyWFierce
@MichaelGFierce: Stanford researchers look at possible Trojan horse delivery. Story via the Stanford Daily | Follow @MichaelGFierce
> FDA deems recalled Covidien devices potentially deadly. Story
> Teleflex hit with FDA warning letter over respiratory devices. Item
Biotech News
@FierceBiotech: AbbVie heads to the FDA with its hep C combo in a race with Gilead, Merck. More | Follow @FierceBiotech
@JohnCFierce: GSK punts programs and rights on cancer to Novartis. MAGE-A3 a mess. Looks like they're done with cancer. Story | Follow @JohnCFierce
@DamianFierce: If I have past two days right: Valeant is buying Pfizer, which won an injunction against Medtronic, which is eyeing Allergan, and all are moving to Ireland. | Follow @DamianFierce
@EmilyMFierce: Experimental drug could thwart measles outbreaks. News | Follow @EmilyMFierce
> FDA OKs Lilly's blockbuster hopeful ramucirumab for stomach cancer. Story
> Analysts brace for a brawl as Valeant moves ahead with Allergan bid. Article
> VC groups put up $165M for a trifecta of biotech rounds. Roundup
Biotech Research News
> Researchers replicate controversial stem cell-cloning method. Story
> Experimental drug could thwart measles outbreaks. Piece
> Stabilizing protein complex in brain offers hope for Alzheimer's treatment. More
> Improved monitoring of zoonotic diseases could predict future Ebola outbreaks. Article
> Cancer stem cells responsible for treatment resistance, cancer relapse. News
> Mouse model could have predicted drug toxicity that killed 5 in clinical trial. Item
Pharma Manufacturing News
> Novartis deals with GSK and Lilly switch up manufacturing landscape. More
> FDA issued import alert after importer tried to ship saline not approved in U.S. Story
> GSK plans to unload site of closed Indian API plant. Article
> Cubist again recalls some Cubicin tied to contractor problem. Piece
> Hospira recalls 7 lots of propofol and one of lidocaine. News
> Novartis close on deal to sell contract patchmaker LTS Lohmann. Item
And Finally... Merck ($MRK) is trying to determine the physical structure of a human monoclonal antibody by crystallizing it in space aboard the SpaceX-3 cargo resupply mission launched April 14 to the International Space Station. Report